Zydus Wellness Limited (BOM:531335)
486.75
-3.35 (-0.68%)
At close: May 25, 2026
Zydus Wellness Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,972 | 3,469 | 2,669 | 3,104 | 3,089 |
Depreciation & Amortization | 1,467 | 276 | 207 | 210 | 193.6 |
Other Amortization | - | 8 | 31 | 40 | 42.6 |
Loss (Gain) From Sale of Assets | 1 | 4 | -35 | 1 | 0.3 |
Loss (Gain) From Sale of Investments | -38 | -98 | -25 | -16 | -11.1 |
Provision & Write-off of Bad Debts | 21 | 3 | 10 | - | 12.3 |
Other Operating Activities | 952 | 406 | 45 | -23 | 105.3 |
Change in Accounts Receivable | 66 | -653 | -761 | -650 | -528.3 |
Change in Inventory | -748 | -398 | -101 | -958 | 30.8 |
Change in Accounts Payable | -538 | 513 | 485 | -530 | -699.3 |
Change in Other Net Operating Assets | -891 | 270 | -61 | -261 | 133.6 |
Operating Cash Flow | 2,264 | 3,800 | 2,464 | 917 | 2,369 |
Operating Cash Flow Growth | -40.42% | 54.22% | 168.70% | -61.28% | -17.40% |
Capital Expenditures | -1,017 | -663 | -285 | -450 | -754.4 |
Sale of Property, Plant & Equipment | 8 | 10 | 21 | 6 | 7.1 |
Cash Acquisitions | -28,498 | -3,690 | - | - | - |
Divestitures | - | 2 | - | - | - |
Investment in Securities | 351 | 547 | -47 | -413 | -205.1 |
Other Investing Activities | 81 | 1,557 | -1,474 | 32 | 92.9 |
Investing Cash Flow | -29,099 | -2,236 | -1,777 | -849 | -859.5 |
Short-Term Debt Issued | - | - | 940 | 1,610 | 192.5 |
Long-Term Debt Issued | 28,897 | - | - | - | - |
Total Debt Issued | 28,897 | - | 940 | 1,610 | 192.5 |
Short-Term Debt Repaid | -350 | -1,390 | - | - | - |
Long-Term Debt Repaid | -313 | -19 | -643 | -2,517 | -1,887 |
Total Debt Repaid | -663 | -1,409 | -643 | -2,517 | -1,887 |
Net Debt Issued (Repaid) | 28,234 | -1,409 | 297 | -907 | -1,695 |
Common Dividends Paid | -382 | -318 | -319 | -319 | -318.8 |
Other Financing Activities | -868 | -136 | -235 | -159 | -324.9 |
Financing Cash Flow | 26,984 | -1,863 | -257 | -1,385 | -2,338 |
Foreign Exchange Rate Adjustments | 19 | - | - | - | - |
Miscellaneous Cash Flow Adjustments | 271 | 166 | - | - | - |
Net Cash Flow | 439 | -133 | 430 | -1,317 | -829.2 |
Free Cash Flow | 1,247 | 3,137 | 2,179 | 467 | 1,614 |
Free Cash Flow Growth | -60.25% | 43.96% | 366.60% | -71.07% | -39.56% |
Free Cash Flow Margin | 3.14% | 11.58% | 9.36% | 2.07% | 8.03% |
Free Cash Flow Per Share | 3.92 | 9.86 | 6.85 | 1.47 | 5.07 |
Cash Interest Paid | - | 136 | 235 | 159 | 324.9 |
Cash Income Tax Paid | - | -29 | 27 | 13 | 41.1 |
Levered Free Cash Flow | -323.63 | 2,279 | 703.75 | -661.13 | 242.81 |
Unlevered Free Cash Flow | 289.5 | 2,352 | 851.88 | -562.38 | 399.75 |
Change in Working Capital | -2,111 | -268 | -438 | -2,399 | -1,063 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.